StockData
Ascentage Pharma Group International logo

Ascentage Pharma Group International (AAPG) income statement

AAPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 3/30
$12.44−0.57 (-4.40%)

Close on Nov 19, 2026Market cap $1.16BP/E –Yield –

Ascentage Pharma Group International income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin
91.5%
Operating margin
–
Net margin
-216.5%
Return on equity, FY2025
-156.5%

Financial strength

Current ratio
1.79
Debt to equity
1.50
Debt to assets
–
Cash to current liabilities
72.8%

Valuation

P/E ratio
–
Price to sales
13.49
Price to book
5.85
Dividend yield
–

See a number that looks wrong?